| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45858ad8420337cf54fe6ca9ecc17337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f10ec45749ea9b78168a98bd19394909 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16Z99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3431 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16Z99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2013-03-01^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22ce359b7189d90566a11ae0d98bd4eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25198b8ffb1cd9832b4bebccab2c44fb |
| publicationDate |
2015-10-08^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015285810-A1 |
| titleOfInvention |
Iaspp phosphorylation and metastatic potential |
| abstract |
Described herein are methods of evaluating metastatic potential of a cancer based on the phosphorylation state and/or intracellular localization of iASPP. Therapeutic regimens designed based on the results of the diagnostic methods are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021087458-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019071257-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10669230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9845287-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10308699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471120-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9957299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10253067-B2 |
| priorityDate |
2012-03-02^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |